Pli­ant posts high-dose da­ta of oral IPF drug with 'quite fa­vor­able' safe­ty, out­lines tri­al plans

Pli­ant Ther­a­peu­tics re­port­ed Mon­day morn­ing that pa­tients who got the high dose of its oral drug for id­io­path­ic pul­monary fi­bro­sis, or IPF, saw their dis­ease …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER